Can velmanase alfa be the next widespread potential therapy for alpha-mannosidosis?

Alpha-mannosidosis (AM) is an autosomal recessive lysosomal storage disorder caused by reduced activity of the enzyme alpha-mannosidase. The disease is characterized by immunodeficiency, facial and skeletal abnormalities, impaired hearing, and intellectual disability. The clinical subtype of AM show...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul Ghani, Sundus, Burney, Sheeba, ul Hussain, Hassan, Abdul Wahid, Maryam, Mumtaz, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498836/
https://www.ncbi.nlm.nih.gov/pubmed/37352513
http://dx.doi.org/10.1097/JS9.0000000000000528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498836/
https://www.ncbi.nlm.nih.gov/pubmed/37352513
http://dx.doi.org/10.1097/JS9.0000000000000528

Ejemplares similares